Search Results - Sanson, M

Cases Illustrative of the Different Methods of Operating for the Stone by Dupuytren, M., Sanson, M.

Get full text Get full text

Glioblastoma targeted therapy: updated approaches from recent biological insights by Touat, M., Idbaih, A., Sanson, M., Ligon, K. L.

Get full text Get full text Get full text

Dramatic improvement in non-AIDS related progressive multifocal leucoencephalopathy by Aure, K, Behin, A, Louillet, F, Lafitte, C, Sanson, M, Vernant, J

Get full text Get full text Get full text

PL02.4.A Chromosome 1p19q codeletion frequency, but not survival, varies according to the IDH mutation subtypes: analysis of 1050 IDH-mutated diffuse gliomas by Picca, A, Berzero, G, Di Stefano, A, Trabelsi, N, Bielle, F, Sanson, M

Get full text Get full text

Parental origin of chromosome 22 alleles lost in meningioma. by Sanson, M, Delattre, O, Couturier, J, Philippon, J, Cophignon, J, Derome, P, Rouleau, G A, Thomas, G

Get full text Get full text

P04.14 IDH1 MUTATION IN LOW-GRADE GLIOMAS RELATED TO EPILEPSY AS INITIAL SYMPTOM by Duran-Peña, A., Mokhtari, K., Marie, Y., Alentorn, A., Delattre, J., Idbaih, A., Sanson, M., Vecht, C.

Get full text Get full text

O8.08 CIC MUTATION IS A POOR PROGNOSIS FACTOR IN 1P19Q CODELETED GLIOMAS, ASSOCIATED TO AN UP-REGULATION OF PROLIFERATION PATHWAYS by Gleize, V., Alentorn, A., Connen de Kérillis, L., Labussière, M., Mangesius, S., Ducray, F., Mokhtari, K., Villa, C., Sanson, M.

Get full text Get full text

OS6.6 CEVOREM Trial: Combination of EVerolimus and Octreotide in REsistant MeningiomasPresentation and Preliminary results by Graillon, T., Peyre, M., Kalamarides, M., Sanson, M., Barrié, M., Campello, C., Tabouret, E., Roche, P., Dufour, H., Chinot, O.

Get full text Get full text

P04.10 IDH-wildtype low grade gliomas: overall survival and prognostic indicators by Berzero, G, Di Stefano, A, Ronchi, S, Villa, C, Marie, Y, Hoang-Xuan, K, Delattre, J, Mokhtari, K, Sanson, M

Get full text Get full text

P08.63 Dose optimization of MK-8628 (OTX015), a small molecule inhibitor of bromodomain and extra-terminal (BET) proteins, in patients with recurrent glioblastoma by Hottinger, A. F., Sanson, M., Moyal, E., Delord, J., Rezai, K., Leung, A., Perez, S., Bekradda, M., Lachaux, N., Chinot, O.

Get full text Get full text

P05.02 KIAA1549:BRAF FUSION GENE IN PEDIATRIC BRAIN TUMORS OF VARIOUS HISTOGENESIS by Baldi, C., Antonelli, M., Badiali, M., Buttarelli, F.R., Moi, L., Nozza, P., Arcella, A., Massimino, M., Sanson, M., Giangaspero, F.

Get full text Get full text

O6.08 COMBINED ANALYSIS OF TERT, EGFR AND IDH STATUS DEFINE DISTINCT PROGNOSTIC CLASSES OF GLIOBLASTOMA by Labussiere, M., Boisselier, B., Mokhtari, K., Di Stefano, A., Rahimian, A., Saulnier, O., Paterra, R., Finocchiaro, G., Marie, Y., Sanson, M.

Get full text Get full text

P01.148 Intra-tumor heterogeneity analysis of low-grade gliomas. A POLA Network study by Alentorn, A, Labreche, K, Dehais, C, Carpentier, C, Ducray, F, Mokhtari, K, Figarella-Branger, D, Sanson, M, Delattre, J, Idbaih, A

Get full text Get full text

O6.07 FGFR3-TACC3 AND EGFR-SEPT14 GENE FUSIONS IN ADULT GLIOMAS by Di Stefano, A. L., Labussiere, M., Frattini, V., Fucci, A., Boisselier, B., Schmitt, Y., Mokhtari, K., Lasorella, A., Iavarone, A., Sanson, M.

Get full text Get full text

P06.18 DNA methylation distance score in lower-grade gliomas has prognostic value: a POLA network study by Alentorn, A., Kamoun, A., Ducray, F., Dehais, C., Mokhtari, K., Uro-Coste, E., Figarella-Branger, D., Delattre, J., Idbaih, A., Sanson, M.

Get full text Get full text

P07.15 Diagnostic value of 2-hydroxyglutarate detection by 1H MR spectroscopy in patients with glioma and correlations with tumor phenotype and tissue dosage by Di Stefano, A. L., Branzoli, F., Ottolenghi, C., Capelle, L., Mokhtari, K., Villa, C. M., Giry, M., Marjanska, M., Lehericy, S., Sanson, M.

Get full text Get full text

P09.14 Clonal and subclonal evolution of 1p/19q co-deleted oligodendrogliomas by Alentorn, A., Daniau, M., Royer-Perron, L., Labreche, K., Duran-Pena, A., Marie, Y., Hoang-Xuan, K., Sanson, M., Delattre, J., Idbaih, A.

Get full text Get full text

EH1.1 Results of the interim analysis of the EORTC randomized phase III CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q co-deletion, an int... by van den Bent, M. J., Erridge, S., Vogelbaum, M., Nowak, A., Sanson, M., Brandes, A. A., Golfinopoulos, V., Gorlia, T., Kros, J. M., Baumert, B. G.

Get full text Get full text

P01.12 Stability of actionable mutations in primary and recurrent glioblastomas by French, P. J., Taphoorn, M., Weyerbrock, A., Sanson, M., Hoeben, A., Lukavoca, S., Lombardi, G., Hanse, M., Watts, C., Golfinopoulos, V., McDermott, U., Robe, P.

Get full text Get full text

OS8.5 How to assess meningioma therapy activity: The CEVOREM independent central review experience by GRAILLON, T, Colin, T, Peyrière, H, Peyre, M, Tabouret, E, Campello, C, Idbaih, A, Boucekine, M, Figarella-Branger, D, Kalamarides, M, Dufour, H, Sanson, M, Chinot, O

Get full text Get full text